baber/WOPTO huggingface dataset:
Patent FI-953932-A0 (FI)
Inventor: DIETZ HANS
IPC: B27B33/20
Filed: 1995-08-22
Abstract: The hacking blades (21) are arranged along the surface (41) on several spirals concentric to the axis (17) of the chipping tool (10) and comprises a primary cutter (50) and a secondary cutter (51). The primary cutter lies in a radial plane (52) to the axis and the secondary cutter in a plane (53) inclined to the radial plane. The primary cutter is adjusted at a first acute angle in relation to a vertical to the cutting direction (54). This acute angle is pref. between 30 and 35 deg. The secondary cutter is set at a second acute angle to the vertical, which is pref. between 10 and 20 deg. The primary cutter forms an edge of a first roof incline of the hacking blade, which is located in the radial plane.
Patent FI-955430-A0 (FI)
Inventor: KELLEY JAMES LEROY
IPC: C07D295/185
Filed: 1995-11-10
Abstract: Novel compounds of formula (I) <CHEM> together with their salts and solvates have a number of uses in medicine, in particular as central muscle relaxants.
Patent IL-64647-A0 (IL)
Title: Trisubstituted pyrimido(5,4-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IPC: C07D487/04
Filed: 1981-12-25
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is optionally substituted alkyl; R2 is hydrogen or optionally substituted alkyl; or R1 and R2, together with each other and the nitrogen atom to which they are attached, form an optionally substituted cyclic imino group; R3 is an optionally substituted cyclic imino group; and R4 is substituted hydroxyl, mercapto or amino; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antithrombotics.
Patent IL-65999-A0 (IL)
Title: Process for the preparation of tetronic acid
IPC: C07C51/367
Filed: 1982-06-07
Abstract: Process for the production of tetronic acid from 4-haloacetoacetic ester which begins by converting a 4-haloacetoacetic ester into the corresponding 4-benzyloxyacetoacetic ester. The 4-benzyl ester is then hydrogenolyzed into an intermediate product. The 4-hydroxyacetoacetic ester is converted by treatment with acid into tetronic acid. The 4-hydroxyacetoacetic ester can be isolated before conversion. The 4-benzyloxyacetoacetic ester can be produced by conversion of the 4-haloacetoacetic ester with a metal salt of benzyl alcohol. The hydrogenolysis can be carried out in the presence of an acid, whereby the 4-hydroxyacetoacetic ester forming in situ is rearranged directly into tetronic acid. The hydrogenolysis can be carried out under pressure in the presence of a hydrogenation catalyst.
Patent IL-66157-A0 (IL)
Title: Sodium triphosphate,process for making it,and its use
IPC: C11D11/02
Filed: 1982-06-29
Abstract: The disclosure relates to sodium tripolyphosphate containing up to 95 weight % phase-I, 0.1 to 22 weight % water of crystallization and 0.01 to 2.0 weight %, calculated as metal, of a compound of the metals selected from calcium, magnesium, zinc or strontium, the compound yielding ions in an aqueous medium. The disclosure also relates to a process for making the tripolyphosphate, and to its uses.
Patent IL-87110-A0 (IL)
Title: Preparation of 3-methylene and 3-halomethylene cepham derivatives
IPC: C07F9/28
Filed: 1988-07-14
Abstract: A process is provided for the preparation of 3-methylene and 3-halomethylene cepham derivatives via 3-phosphoniomethyl-3-cephem derivatives, which in turn can be prepared from 3-halomethyl-3-cephem derivatives. The preparation can be carried out with or without isolating the intermediate phosphonium cephem compounds. The 3-methylene and 3-halomethylene cepham derivatives and in particular the 1-oxo and 1,1-dioxo cepham compounds are also prepared by reducing a 3-halomethyl-3-cephem derivative with activated metal, preferably zinc or magnesium.
Patent IL-92265-A0 (IL)
Title: Expression enhancer and employment thereof to increase the yield in the expression of recombinant genes
IPC: C12N9/64
Filed: 1989-11-09
Abstract: An expression enhancer has a DNA sequence which is able after transcription to form a t-RNA cloverleaf structure and hybridises in the region of the DNA which after transcription forms the anticodon loop in the cloverleaf structure with an oligonucleotide of the sequence 5'-GACTTAGAAGGTCGTT-3' or the sequence complementary thereto (5'-AACGACCTTCTAAGTC-3'). It can be used to increase the yield on expression of a recombinant gene by transformation of suitable host cells with an expression vector containing the recombinant gene by likewise introducing it, in a form which can be expressed, and expressing it in the host cells.
Patent IL-95134-A0 (IL)
Title: Method for inhibiting virus replication in mammalian cells using pokeweed antiviralprotein-monoclonal antibody conjugates
IPC: A61K38/00
Filed: 1990-07-20
Abstract: Pokeweed antiviral protein (PAP) - monoclonal antibody conjugates capable of inhibiting virus replication in mammalian cells without detectable cytotoxicity are provided.
Patent AU-PP022297-A0 (AU)
Title: Vitamin coating
IPC: A61K9/66
Filed: 1997-11-06
Abstract: The invention disclosed herein includes a vitamin composition encapsulated in a soft or hard shell capsule, said vitamin composition comprising water soluble vitamin particles suspended in a fill liquid, wherein said water soluble vitamin particles are coated with a material that is substantially insoluble in the fill liquid and the shell of the capsule, but soluble in the gastrointestinal tract of a mammal, and the coated water soluble vitamin particles are of a size that are suitable for encapsulating as a suspension in said capsule. The invention also includes a process for manufacturing the same. Vitamin containing capsules according to this invention are discoloration-resistant.
Patent AU-PP872899-A0 (AU)
Title: A vehicle steering system
IPC: B62D5/12
Filed: 1999-02-17
Abstract: A Vehicle steering system (3) for wheel assemblies comprises a double-ended hydraulic cylinder (5) mounted to the main frame (7), a piston rod (9) mounted for sliding movement in the cylinder, a pair of tie rods, each tie rod (11) being coupled at an inner end to the piston rod and at an outer end to one of the wheel assemblies (13, 15) so as to provide differential steering movement of the wheel assemblies as the piston rod is moved in the cylinder.
Patent FI-20055078-A0 (FI)
Inventor: ALA-LUUKKO SAMI
IPC: H04L29/08
Filed: 2005-02-18
Abstract: In order to facilitate the maintaining of associations re- quired in inter-domain communications, preferably name (41-1) and address information (41-2) on domains and in- formation on interworking agreements (41-3) between dif- ferent domains is maintained in a reliable network external to said domains. A network node (41) via which inter- domain traffic is routed is arranged to use said maintained information when checking whether or not a sender of a message is the one the sender claims to be and preferably also whether or not an agreement exists between the sender's domain and a receiver's domain. Provided that the sender is the claimed one, the message is forwarded, preferably to an address maintained for the receiver's do- main.
Patent IL-102166-A0 (IL)
Title: Grafting vinyl monomers on particulate olefin polymers
IPC: C08F255/02
Filed: 1992-06-10
Abstract: Uniformly grafted, particulate olefin polymers are formed by free radical-initiated grafting of a non-homopolymerising vinyl monomer at free radical sites on a particulate olefin polymer with (a) a min. pore vol. fraction of 0.07 where above 40% of the pores have a dia. above 1 micron, and (b) a wt. average dia. of 0.4-7 mm. The process comprises either, (i) (a) irradiating the polyolefin at 10-85 deg.C with high energy ionising radiation to produce free radical sites; (b) treating the irradiated polyolefin at up to 100 deg.C for 3 minutes or more with 0.2-20 wt. % (of the total wt. of polyolefin + grafting monomer) of a non-free radical homopolymerising but free-radical graftable vinyl monomer; (c) simultaneously or successively in either order: (1) deactivating all residual free radicals in the grafted polyolefin, and (2) removing all unreacted grafting monomer; or (ii) (a') treating the polymer at 60-125 deg. C with 0.1-6.0 phr of an organic free-radical polymerisation initiator with a decompsn. half life of 1-240 minutes at the temp. used; and (b') during, following or overlapping the initiator treatment, treating the polyolefin with 0.2-20 wt. % of a grafting monomer.
Patent IL-111942-A0 (IL)
Title: A transdermal therapeutic system containing a parasympathomimetic compound and a parasympatholytic compound
IPC: A61K31/27
Filed: 1994-12-09
Abstract: PCT No. PCT/EP94/04048 Sec. 371 Date Jul. 30, 1996 Sec. 102(e) Date Jul. 30, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/15755 PCT Pub. Date Jun. 15, 1995A transdermal therapeutic system for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins is characterized in that it has a pharmaceutical formulation with an active substance combination consisting of at least one parasympathomimetically active substance and at least one parasympatholytically active substance.
Patent IL-115522-A0 (IL)
Title: Methods for producing enhanced antigenic helicobacter sp and vaccines comprising same
IPC: A61P37/04
Filed: 1995-10-05
Abstract: Methods using in vitro processes are disclosed for inducing or enhancing expression of enteric bacterial antigens or virulence factors. The methods, therefore, produce antigenically enhanced enteric bacteria. Also methods for using the antigenically enhanced bacteria are also disclosed, as well as vaccines containing the enteric bacteria. Specifically a whole enteric bacterium or components thereof are provided by Helicobacter species. Also there are other enteric bacteria which are useful for the disclosed invention; such as Campylobacter jejuni.
Patent IL-116559-A0 (IL)
Title: Chimeric proteins
IPC: C07K19/00
Filed: 1995-12-26
Abstract: A chimeric protein comprising a Pseudomonas aeruginosa exotoxin (PE) moiety linked to a myelin basic protein (MBP) moiety is disclosed. The MBP moiety is selected from the group comprising: (a) MBP; (b) amino acids 69-88 of guinea-pig myelin basic protein or an antigenic portion thereof; (c) amino acids 84-102 of human myelin basic protein or an antigenic portion thereof; (d) amino acids 143-168 of human myelin basic protein or an antigenic portion thereof; and (e) an amino acid sequence in which one or more amino acids have been deleted, added, substituted or mutated in the amino acid sequences of (a), (b), (c) or (d), the modified sequence of (e) retaining at least 75% homology with the amino acid sequences of (a), (b), (c) or (d), respectively. Each of the MBP moieties of (b), (c) and (d) are linked to the PE moiety by a pentapeptide linker repeated 1-3 times. The chimeric protein is useful in treating autoimmune diseases, and especially multiple sclerosis.
Patent IL-123146-A0 (IL)
Title: Monitoring of covert marks
IPC: B44B7/00
Filed: 1996-08-05
Abstract: PCT No. PCT/GB96/01898 Sec. 371 Date Jul. 2, 1997 Sec. 102(e) Date Jul. 2, 1997 PCT Filed Aug. 5, 1996 PCT Pub. No. WO97/06016 PCT Pub. Date Feb. 20, 1997A method and apparatus for monitoring a body having a reflective surface (1), a coating layer (2) of material transparent to visible light present on the surface (1) and producing a covert optical discontinuity in an imagewise distribution on the layer (2); the imagewise distribution is such that it is visible via polarized light (7) and viewing through a polarized filter (8).
Patent IL-126802-A0 (IL)
Title: Vitamin d analogs and methods of preparing these compounds
IPC: A61P3/00
Filed: 1997-05-02
Abstract: The invention relates to vitamin D analogs of general formula (I) wherein: R1 is a hydrogen atom or a substituent selected from the group consisting of hydroxy, CH2OH, CH2CH2OH, CH2CH2CH2OH, OCH3, OCH2OH, OCH2CH2OH and OCH2CH2CH2OH; R2 is a hydrogen atom or a substituent selected from the group consisting of OCH3, OCH2OH, CHm(CH2OH)n(CH2CH2OH)p, (CH2)qOH and O(CH2)rOH; wherein: m is 0 or 1, p, q and n are 0-3, r is 1-3 and m+n+p=3; with the proviso that R1 and/or R2 contain at least one OH group; R3 is a straight or branched, saturated or unsaturated aliphatic hydrocarbon of 6-13 C atoms which may be substituted with one or more substituents from the group hydroxy or fluoro. The invention further relates to methods of preparing these compounds, a pharmaceutical composition containing these compounds and to their use in pharmacotherapy and cosmetics.
Patent IL-130163-A0 (IL)
Title: Building element
IPC: E04B7/20
Filed: 1997-11-28
Abstract: A building element (1) comprising an outer sheath and an inner core, the sheath being formed of a material having a greater tensile strength than compressive strength and the core having a greater compressive strength than tensile strength; wherein the outer sheath is longitudinally extending and has a first face (7) and a second face (8) which are spaced apart, first (9) and second (21) edges and a first and second end; wherein the first face (7) and the second face (8) are joined at the first (9) and second (21) edges to form the outer sheath as a continuous body, and wherein the first edge (9) and the second edge (21) are so shaped that the first edge (9) of one such building element (1) is adapted to locate in the second edge (21) of another such building element (1).
Patent IL-136360-A0 (IL)
Title: 5-aminopyrazole-4- carboxylate derivatives and processes for the preparation thereof
IPC: C07D231/38
Filed: 2000-05-25
Abstract: A 5-aminopyrazole-4-carboxylate derivative represented by the formula (1) is prepared by reacting a compound represented by the formula (2) with a hydrazine compound represented by the formula (3) or hydrate, hydrochloride, hydrobromide or sulfate of the same according to the reaction formula (C): <CHEM> wherein R<1> is a straight or branched C1 to C4 alkyl group which can be substituted with a halogen atom, R<2> is a hydrogen atom, straight or branched C1 to C4 alkyl group or an unsubstituted or substituted phenyl group, and R<3> is a straight or branched C1 to C4 alkyl group, and M is an alkali metal. <??>The 5-aminopyrazole-4-carboxylate derivative obtained by the preparation process of the invention is useful for an intermediate of agricultural chemicals and medicines, fungicides in particular.
Patent IL-155264-A0 (IL)
Title: Water filter cartridge having a proportional flow feeder
IPC: B01D27/06
Filed: 2001-10-15
Abstract: More specifically, the present invention features an improved feeder tube for a water treatment cartridge that provides treatment by a solid compound for a slipstream of untreated water flowing through the cartridge. The feeder tube includes a first end and a second end, such that the slipstream of water generally flows into the feeder tube at the second end and out of the feeder tube at the first end. A bottom plug assembly is in operational relationship with the second end and includes a porous plug being sized and configured to provide filtration and purification for the slipstream portion of the water.
Patent IL-157496-A0 (IL)
Title: Method for producing d-pantothenic acid and/or salts thereof as additive to animal feed
IPC: C12P13/00
Filed: 2002-02-20
Abstract: The invention relates to an improved method for producing D-pantothenic acid and/or salts thereof and to the use thereof as an additive for animal feed.
Patent IL-160404-A0 (IL)
Title: Prostaglandin compositions and methods of treatment for male erectile dysfunction
IPC: A61K47/14
Filed: 2002-09-06
Abstract: The invention provides methods of treating erectile dysfunction comprising the step of placing within the fossa navicularis of the patient an effective erection-inducing amount of a prostaglandin E1 composition of a semi-solid consistency, as well as suitable applicators. The composition comprises prostaglandin E1, a penetration enhancer, a polysaccharide gum, a lipophilic compound, and an acidic buffer system. The penetration enhancer is an alkyl-2-(N,N-disubstituted amino)-alkanoate ester, an (N,N-disubstituted amino)-alkanol alkanoate, or a mixture of these. The lipophilic compound may be an aliphatic C1 to C8 alcohol, aliphatic C2 to C30 ester, an aliphatic C8 to C30 ester, or a mixture of these. The composition includes a buffer system capable of providing a buffered pH value for said composition in the range of about 3 to about 7.4.
Patent IL-165155-A0 (IL)
Title: Process for the manufacture of quinoline derivatives
IPC: C07D491/04
Filed: 2004-11-11
Abstract: A process for the preparation of the compounds of general formula (I); by reacting a quinoline-3-carboxylic acid ester derivative of formula A with an aniline derivative of formula B in a solvent selected from straight- or branch-chaineded alkanes and cycloalkanes or mixtures thereof with a boiling point between 80 and 200 C.
Patent IL-165167-A0 (IL)
Title: Laser range detection
IPC: G01S11/12
Filed: 2004-11-11
Abstract: Apparatus for determining a range to a coherent light source emitting a coherent light beam, the apparatus including an image sensor and a processor, the processor being coupled with the image sensor, the image sensor including an imaging plane, for capturing an image of the wave front of the coherent light beam, the image including at least one light speckle, wherein the processor identifies the light speckle on the captured image, determines the characteristic diameter of the identified light speckle, and determines the range by squaring the characteristic diameter and dividing the result of the squaring by the wavelength of the coherent light beam and by a proportionality constant.
Patent IL-173603-A0 (IL)
Title: A process for producing a rose with a modified color
IPC: C12N15/82
Filed: 2006-02-08
Abstract: A method for producing a rose  characterized by  artificially suppressing the rose endogenous metabolic pathway and expressing the pansy gene coding for flavonoid 3',5'-hydroxylase.
Patent IL-183508-A0 (IL)
Title: System and method for beam expansion with near focus in a display device
Filed: 2007-05-29
Abstract: The present invention relates to an optical devices comprising: a light-guiding structure (1) for guiding optical waves by means of total internal reflection, having two opposite major surfaces (1a, 1b) extending essentially parallel to the major plane of the structure (1), a first light-coupling element (2) being carried by one of the opposite major surfaces (1a,1b) of said structure (1) for incoupling optical waves from an image source (3) into the light-guiding structure (1), at least one second light-coupling element (4) being carried by one of the opposite major surfaces (1a,1b) of said structure (1) and being laterally displaced along the major plane of the structure (1) from said first light-coupling element (2) for outcoupling optical waves out of said structure (1) to be viewed by observer´s eye. For improving the ergonomics of this optical device it is characterized by at least one of the opposite major surfaces (1a, 1b) at the location of at least one of the first or the at least one second light-coupling elements (2,4) of the light-guiding structure (1) comprising a given finite curvature radius corresponding to the apparent focal distance for providing a virtual image at the preferable focal distance.
Patent IL-190784-A0 (IL)
Title: Apparatus and method for forming a hole in a hollow organ
Filed: 2008-04-10
Abstract: The invention relates to an apparatus and method for forming a hole in a wall of a hollow organ. The applicator includes a hole forming element for forming a hole in the wall of the organ, a positioning means (300) for positioning the hole forming element, and a retractor element (500). In addition, the applicator includes a sequencing means (600) for coordinating the relative movement of the retractor element and the hole forming element in a sequential manner to thereby carry out a procedure for forming a hole in the wall of the hollow organ. The sequencing means may further include a safety latch element operatively coupled to the retracting means and the hole forming element. The safety latch of the invention prevents damage to the internal surface of the organ during the formation of the hole.
Patent IL-205354-A0 (IL)
Title: Spiroindolinone derivatives
Filed: 2010-04-26
Abstract: There are provided compounds of the formula and pharmaceutically acceptable salts and esters thereof wherein W, V, X, Y, A, R and R′ are as described herein. The compounds are useful as anticancer agents.
Patent RO-135744-A0 (RO)
Title: Asphalt concrete made of aggregates and waste derived from glass and recycled plastics and process for preparing the same
Inventor: DEBIE DENNIS
IPC: E01C7/26
Filed: 2021-12-17
Abstract: The invention relates to asphalt mixture materials to be used as a single basic and connecting road carpet layer, which, in addition to conventional mineral aggregates, also comprises granular particles of glass waste and plastics wastes regardless of the resin identification code and to a process for preparing the same. According to the invention, the materials have the following compositions: 1. material with total replacement of natural aggregates, composed of glass waste with a grain size between 0...4 mm, in a percentage of 55...70% of the total mass of the mixture, plastic waste ground to dimensions between 0...10 mm, in a percentage of 25...40% of the total mass of the mixture and at most 5% filler, and 2. granular glass waste material in sorts between 0...4 and 4...8 mm representing 15...40% of the total mass of the mixture, plastic waste ground to 0...10 mm representing 5...20% of the total mass of the mixture, 40...70% of the total mass of the mixture being conventional stone-type mineral aggregates, and the amount of filler is 3...5% of the total mass of the mixture. According to the invention, the process consists in mixing the glass together with the aggregates and the filler at a temperature between 160...180°C, after which the bitumen heated to 180°C is added and the mixture is stirred for 30...35 seconds, the ground plastic component is added and the stirring continues for another 10...15 seconds until a polymerized asphalt mixture is obtained.
Patent RO-137283-A0 (RO)
Title: Radiation-protection structure used in doors, walls and windows of work premises with x-ray sources
Inventor: ONICEL CIPRIAN
IPC: C08L79/08
Filed: 2022-10-20
Abstract: The invention relates to a radiation-protection structure to be used in doors, walls and windows of work premises with X-ray sources. According to the invention, the structure consists essentially of a sandwich-type structure, containing particle boards, of chipboard, MDF or OSB type, fixed to one another by means of an adhesive (3), all this structure being placed along the entire contour in some metal frames made of aluminum profile, thus, in the case of a sandwich-type swinging door, it contains a sequence of layers, an upper layer (2) of particle board, chipboard, MDF or OSB, an inner layer (4) of particle board, chipboard, MDF or OSB, a layer (5) of lead and another lower layer (6) also made of particle boards, chipboard, MDF or OSB, all of this being fixed together by means of some layers (3) of adhesive, this whole sandwich being bordered by a frame (1) made of aluminum profile of U type with inner rib, in the shape of a coin, the inner rib of this profile (1) being mounted in a perimeter milling cut in the inner layer (4), on the entire contour of a door leaf (15), the technical effect of these solutions being that the X-ray losses outside the working premises are limited or even excluded.